Gilead Sciences rose to the top of the pharmaceutical industry company rankings on the strength of its hepatitis C franchise, but will this be enough going forward? That is the…
Stefan Oschmann, chairman of the Executive Board and CEO of Merck KGaA, recently outlined the company’s progress in meeting its longer-term strategic goals. So how is the company doing? The…
Pfizer announced this week that the company will not pursue separating the company into two independent companies, one focused on the company’s innovator products and the second on the company’s…
The Challenges and Opportunities for GSK’s New CEO
GlaxoSmithKline’s (GSK) has announced that Emma Walmsley, currently chief executive officer (CEO) of GSK’s Consumer Healthcare Division, has been appointed GSK CEO Designate and will succeed Andrew Witty as GSK…
Pfizer’s $14 Billion Acquisition of Medivation: What It Means for Pfizer
Pfizer has agreed to acquire Medivation, a pharmaceutical company specializing in small-molecule oncology drugs, for $14 billion in a friendly acquisition bid, beating out Sanofi and other suitors that had…
A recent analysis by Deloitte Consulting gained feedback from chief executive officers (CXOs) and chief executives-in-waiting (CXOWs), the latter including those who are next in line to the C-suite, to…
Brexit Round Two: What Is Next For The UK Pharma Industry?
The policy direction of the pharmaceutical industry in the UK in the wake of Brexit took another turn when the UK Life Science Minister George Freeman was re-assigned to a…
The United Kingdom’s decision to exit the European Union (EU) via a majority vote in a public referendum has created a plethora of questions for global commerce. DCAT Value Chain…
Sanofi CEO Olivier Brandicourt is pushing hard to acquire the biopharmaceutical company, Medivation, as Sanofi moves forward to reshape its portfolio and drive growth. So where does the company stand?…
Having successfully floated its material sciences business, Covestro, Bayer is now positioned as a pure-play life sciences company with projected 2016 sales in its life sciences business of approximately EUR…
